RGEN
Repligen Corp
Price:  
119.99 
USD
Volume:  
734,886.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN Relative Valuation

-78.0%
Upside

As of 2026-03-09, the Relative Valuation of Repligen Corp (RGEN) is 26.36 USD. This relative valuation is based on P/E multiples. With the latest stock price at 119.99 USD, the upside of Repligen Corp based on Relative Valuation is -78.0%.

The range of the Relative Valuation is 20.92 - 31.13 USD.

Range Selected
Trailing P/E multiples 24.1x - 28.1x 26.6x
Forward P/E multiples 22.2x - 24.9x 23.7x
Fair Price 20.92 - 31.13 26.36
Upside -82.6% - -74.1% -78.0%
119.99 USD
Stock Price
26.36 USD
Fair Price

RGEN Relative Valuation - Historical P/E Data

Date P/E
2026-03-06 138.14
2026-03-05 143.94
2026-03-04 144.88
2026-03-03 141.67
2026-03-02 143.87
2026-02-27 148.20
2026-02-26 153.87
2026-02-25 152.13
2026-02-24 155.04
2026-02-23 155.88
2026-02-20 156.20
2026-02-19 157.98
2026-02-18 159.00
2026-02-17 155.89
2026-02-13 157.08
2026-02-12 152.69
2026-02-11 160.49
2026-02-10 164.70
2026-02-09 165.30
2026-02-06 163.69
2026-02-05 160.79
2026-02-04 168.21
2026-02-03 172.95
2026-02-02 173.98
2026-01-30 171.96
2026-01-29 180.02
2026-01-28 184.26
2026-01-27 188.38
2026-01-26 188.05
2026-01-23 186.89
2026-01-22 193.33
2026-01-21 195.68
2026-01-20 188.04
2026-01-16 186.53
2026-01-15 186.15
2026-01-14 186.54
2026-01-13 192.62
2026-01-12 193.87
2026-01-09 192.05
2026-01-08 191.59
2026-01-07 194.62
2026-01-06 198.32
2026-01-05 195.07
2026-01-02 189.21
2025-12-31 188.65
2025-12-30 191.79
2025-12-29 190.80
2025-12-26 191.35
2025-12-24 190.72
2025-12-23 191.52